Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

L Louis J. Aronne (Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medicine, New York) D Deborah Bade Horn (University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston) C Carel W. le Roux (University College Dublin School of Medicine, Dublin) W Wayne Ho (Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles) B Beverly L. Falcon (Eli Lilly, Indianapolis) E Elisa Gomez Valderas (Eli Lilly, Indianapolis) S Sagar Das (Eli Lilly, Indianapolis) C Clare J. Lee (Eli Lilly, Indianapolis) L Leonard C. Glass (Eli Lilly, Indianapolis) C Cagri Senyucel (Eli Lilly, Indianapolis) J Julia P. Dunn (Eli Lilly, Indianapolis)

Article Details

Volume / Issue Vol. 393, Issue 1
Published July 03, 2025
Pages 26-36
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (11)

L

Louis J. Aronne

Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medicine, New York

D

Deborah Bade Horn

University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston

C

Carel W. le Roux

University College Dublin School of Medicine, Dublin

W

Wayne Ho

Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles

B

Beverly L. Falcon

Eli Lilly, Indianapolis

E

Elisa Gomez Valderas

Eli Lilly, Indianapolis

S

Sagar Das

Eli Lilly, Indianapolis

C

Clare J. Lee

Eli Lilly, Indianapolis

L

Leonard C. Glass

Eli Lilly, Indianapolis

C

Cagri Senyucel

Eli Lilly, Indianapolis

J

Julia P. Dunn

Eli Lilly, Indianapolis